 <h1>Lenvatinib Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to lenvatinib: capsule oral, oral capsule</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, lenvatinib may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking lenvatinib:</p><p>
<i>More common</i>
</p><ul>
<li>Bladder pain</li>
<li>bleeding gums</li>
<li>bloating or swelling of the face, arms, hands, lower legs, or feet</li>
<li>blood in the urine or stools</li>
<li>blurred vision or other change in vision</li>
<li>chest pain or discomfort</li>
<li>chills</li>
<li>cloudy urine</li>
<li>confusion</li>
<li>constipation</li>
<li>cough</li>
<li>coughing up blood</li>
<li>decreased frequency or amount of urine</li>
<li>depressed mood</li>
<li>diarrhea</li>
<li>difficulty with breathing or swallowing</li>
<li>dilated neck veins</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>dry skin and hair</li>
<li>extreme tiredness or weakness</li>
<li>fainting</li>
<li>feeling cold</li>
<li>fever</li>
<li>hair loss</li>
<li>hoarseness or husky voice</li>
<li>increase in heart rate</li>
<li>increased menstrual flow or vaginal bleeding</li>
<li>lower back or side pain</li>
<li>muscle cramps in the hands, arms, feet, legs, or face</li>
<li>muscle stiffness</li>
<li>nervousness</li>
<li>nosebleeds</li>
<li>numbness and tingling around the mouth, fingertips, or feet</li>
<li>painful or difficult urination</li>
<li>pale skin</li>
<li>paralysis</li>
<li>pinpoint red spots on the skin</li>
<li>pounding in the ears</li>
<li>prolonged bleeding from cuts</li>
<li>rapid or irregular breathing</li>
<li>rapid weight gain</li>
<li>red or black, tarry stools</li>
<li>red or dark brown urine</li>
<li>redness, swelling, or pain of the skin</li>
<li>scaling of the skin on the hands and feet</li>
<li>severe headache</li>
<li>slow or fast heartbeat</li>
<li>sore throat</li>
<li>stomach pain and bloating</li>
<li>swelling of the face, fingers, feet, or lower legs</li>
<li>tingling of the hands or feet</li>
<li>tremor</li>
<li>ulceration of the skin</li>
<li>ulcers, sores, or white spots in the mouth</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
<li>unusual weight gain or loss</li>
<li>vomiting</li>
<li>wrinkled skin</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Clay-colored stools</li>
<li>difficulty with speaking</li>
<li>heartburn or indigestion</li>
<li>inability to move the arms, legs, or facial muscles</li>
<li>pain or discomfort in the arms, jaw, back, or neck</li>
<li>severe abdominal or stomach pain, cramping, or burning</li>
<li>stomach pain or tenderness</li>
<li>troubled breathing with exertion</li>
<li>vomiting of material that looks like coffee grounds</li>
<li>yellow eyes or skin</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Abnormal small opening</li>
<li>impaired wound healing</li>
<li>loss of appetite</li>
<li>severe nausea or vomiting</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of lenvatinib may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Belching</li>
<li>change or loss of taste</li>
<li>decreased weight</li>
<li>dry mouth</li>
<li>hair loss or thinning of the hair</li>
<li>itching or skin rash</li>
<li>muscle or joint pain</li>
<li>swelling or inflammation of the mouth</li>
<li>trouble sleeping</li>
<li>voice changes</li>
</ul><p>
<!-- end capsule oral, oral capsule --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to lenvatinib: oral capsule</i></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hypertension (73%)</p>
<p><b>Common</b> (1% to 10%): Hypotension, QT prolongation, arterial thromboembolic event, cardiac dysfunction (cardiac failure, decreased ventricular function, pulmonary edema)<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Very common</b> (10% or more): Proteinuria (34%), renal impairment (14%)</p>
<p><b>Common</b> (1% to 10%): Increased creatinine, renal failure<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Hemorrhagic events (35%)</p>
<p><b>Common</b> (1% to 10%): Decreased platelet count<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Hyperbilirubinemia, increased alkaline phosphatase, increased ALT, increased AST</p>
<p><b>Very rare</b> (less than 0.01%): Hepatic failure, acute hepatitis<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (67%), nausea (47%), stomatitis (41%), vomiting (36%), abdominal pain (31%), constipation (29%), oral pain (25%), dry mouth (17%), dyspepsia (13%)</p>
<p><b>Common</b> (1% to 10%): GI perforation/fistula, increased serum amylase, increased lipase<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (38%), dysgeusia (18%), dizziness (15%)</p>
<p><b>Common</b> (1% to 10%): Reversible posterior leukoencephalopathy syndrome<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Very common</b> (10% or more): TSH suppression impairment (up to 88%)<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Decreased appetite (54%), weight decreased (51%)</p>
<p><b>Common</b> (1% to 10%): Dehydration, hypoalbuminemia, hypomagnesemia, hypoglycemia, hypocalcemia, hypercalcemia, hyperkalemia, hypercholesterolemia<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Palmar-plantar erythrodysesthesia (32%), rash (21%), alopecia (12%)</p>
<p><b>Common</b> (1% to 10%): Hyperkeratosis<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Urinary tract infections (11%)<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Dental and oral infections (10%)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Arthralgia/myalgia (62%)<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (67%), peripheral edema (21%)<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Insomnia (12%)<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Dysphonia (31%), cough (24%), epistaxis (12%)</p>
<p><b>Common</b> (1% to 10%): Pulmonary embolism<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Lenvima (lenvatinib)." Eisai Inc, Woodcliff Lake, NJ. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>How long does it take to work?</li>
<li>Is this an immunotherapy or chemotherapy drug?</li>
<li>Is this used for endometrial cancer?</li>
<li>Lenvatinib vs sorafenib: for first line treatment in HCC?</li>
<li>How does it work?</li>
<li>How is it taken / administered?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about lenvatinib</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>2 Reviews</li>
<li>Drug class: multikinase inhibitors</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Lenvatinib &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Lenvima</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Thyroid Cancer</li>
<li>Hepatocellular Carcinoma</li>
<li>Renal Cell Carcinoma</li>
<li>Endometrial Cancer</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to lenvatinib: oral capsule</i></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hypertension (73%)</p><p><b>Common</b> (1% to 10%): Hypotension, QT prolongation, arterial thromboembolic event, cardiac dysfunction (cardiac failure, decreased ventricular function, pulmonary edema)<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Very common</b> (10% or more): Proteinuria (34%), renal impairment (14%)</p><p><b>Common</b> (1% to 10%): Increased creatinine, renal failure<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Hemorrhagic events (35%)</p><p><b>Common</b> (1% to 10%): Decreased platelet count<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Hyperbilirubinemia, increased alkaline phosphatase, increased ALT, increased AST</p><p><b>Very rare</b> (less than 0.01%): Hepatic failure, acute hepatitis<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (67%), nausea (47%), stomatitis (41%), vomiting (36%), abdominal pain (31%), constipation (29%), oral pain (25%), dry mouth (17%), dyspepsia (13%)</p><p><b>Common</b> (1% to 10%): GI perforation/fistula, increased serum amylase, increased lipase<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (38%), dysgeusia (18%), dizziness (15%)</p><p><b>Common</b> (1% to 10%): Reversible posterior leukoencephalopathy syndrome<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Very common</b> (10% or more): TSH suppression impairment (up to 88%)<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Decreased appetite (54%), weight decreased (51%)</p><p><b>Common</b> (1% to 10%): Dehydration, hypoalbuminemia, hypomagnesemia, hypoglycemia, hypocalcemia, hypercalcemia, hyperkalemia, hypercholesterolemia<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Palmar-plantar erythrodysesthesia (32%), rash (21%), alopecia (12%)</p><p><b>Common</b> (1% to 10%): Hyperkeratosis<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Urinary tract infections (11%)<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Dental and oral infections (10%)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Arthralgia/myalgia (62%)<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (67%), peripheral edema (21%)<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Insomnia (12%)<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Dysphonia (31%), cough (24%), epistaxis (12%)</p><p><b>Common</b> (1% to 10%): Pulmonary embolism<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Lenvima (lenvatinib)." Eisai Inc, Woodcliff Lake, NJ. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>How long does it take to work?</li>
<li>Is this an immunotherapy or chemotherapy drug?</li>
<li>Is this used for endometrial cancer?</li>
<li>Lenvatinib vs sorafenib: for first line treatment in HCC?</li>
<li>How does it work?</li>
<li>How is it taken / administered?</li>
</ul><h2>More about lenvatinib</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>2 Reviews</li>
<li>Drug class: multikinase inhibitors</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Lenvatinib &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Thyroid Cancer</li>
<li>Hepatocellular Carcinoma</li>
<li>Renal Cell Carcinoma</li>
<li>Endometrial Cancer</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>